Chordia Therapeutics (190A) · InitiativeRestated
Listing on the Tokyo Stock Exchange Growth Market and Public Offering
First written in FY2024-Q3. 1 of 2 entries say "Restated". Latest entry: FY2024.
2entries
1years
0from disclosures
How it moved
Same theme, other companies
Tokyo Stock Exchange Mothers/Growth Market Listing and Growth and Talent Investment Through a Public OfferingA theme 268 companies write about · 0 as a headwind · 272 as a tailwind
The whole theme swung hardest in 2022: 23 of 90 companies on the "Worse" side.
59 other companies' latest entry also says "Restated".
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 197 companies compared. The sentences above are computed from all 197.Comparing 200 of the theme's 273 threads.Full recordFilings, disclosures and news, newest first
- FY2024RestatedAnnual report
「The Company's shares were listed on the Growth Market of the Tokyo Stock Exchange effective 14 June 2024.」
The listing on the Growth Market of the Tokyo Stock Exchange was also confirmed in the full-year report. - FY2024-Q3First statedAnnual report
「The Company listed its shares on the Growth Market of the Tokyo Stock Exchange on 14 June 2024. In connection with the listing, it issued new shares through a public offering pursuant to resolutions of meetings of the Board of Directors held on 10 May 2024 and 28 May 2024, and payment was completed on 13 June 2024.」
In connection with the listing on 14 June 2024, payment for the public offering of new shares was completed on 13 June 2024, with the proceeds designated for working capital.